BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 34245137)

  • 1. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
    Lendvai G; Szekerczés T; Illyés I; Csengeri M; Schlachter K; Szabó E; Lotz G; Kiss A; Borka K; Schaff Z
    PLoS One; 2021; 16(6):e0253065. PubMed ID: 34129628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis.
    Shichi S; Sugiyama K; Asahi Y; Shirakawa C; Nakamoto H; Kimura S; Wakizaka K; Aiyama T; Nagatsu A; Orimo T; Kakisaka T; Taketomi A
    Cancer Med; 2024 May; 13(9):e7238. PubMed ID: 38716625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer.
    Matsumoto M; Onda S; Igarashi Y; Hamura R; Uwagawa T; Furukawa K; Shirai Y; Gocho T; Haruki K; Ikegami T
    Surg Today; 2024 May; 54(5):407-418. PubMed ID: 37700170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in immunotherapy for biliary tract cancers.
    Zhao Y; Yang M; Feng J; Wang X; Liu Y
    Chin Med J (Engl); 2024 Mar; 137(5):524-532. PubMed ID: 37646139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
    Sun BY; Yang ZF; Wang ZT; Liu G; Zhou C; Zhou J; Fan J; Gan W; Yi Y; Qiu SJ
    World J Surg Oncol; 2023 Mar; 21(1):90. PubMed ID: 36899373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
    Langenbecks Arch Surg; 2024 Jan; 409(1):45. PubMed ID: 38252293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.
    Zhou Y; Gu Q; Zhu L; Zhang S; Wu H; Pu X; Jiang C; Chen J
    Cell Prolif; 2023 Dec; 56(12):e13513. PubMed ID: 37401015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients.
    Kim H; Kim HJ; Park YT; Kim JS
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):371-376. PubMed ID: 37774230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.
    Rodríguez-Barrueco R; Latorre J; Devis-Jáuregui L; Lluch A; Bonifaci N; Llobet FJ; Olivan M; Coll-Iglesias L; Gassner K; Davis ML; Moreno-Navarrete JM; Castells-Nobau A; Plata-Peña L; Dalmau-Pastor M; Höring M; Liebisch G; Olkkonen VM; Arnoriaga-Rodríguez M; Ricart W; Fernández-Real JM; Silva JM; Ortega FJ; Llobet-Navas D
    Adv Sci (Weinh); 2022 Feb; 9(4):e2104759. PubMed ID: 34898027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort study.
    Tzedakis S; Challine A; Katsahian S; Malka D; Jaquet R; Marchese U; Gaillard M; Coriat R; Dhote A; Mallet V; Jeddou H; Boudjema K; Fuks D; Lazzati A
    Eur J Cancer; 2024 May; 202():114018. PubMed ID: 38502987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer.
    Jansson H; Cornillet M; Sun D; Filipovic I; Sturesson C; O'Rourke CJ; Andersen JB; Björkström NK; Sparrelid E
    Front Oncol; 2023; 13():1169537. PubMed ID: 37404757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced gamma-synuclein in regards to DC function.
    Song JY; Lim DS
    Cell Death Dis; 2015 Sep; 6(9):e1883. PubMed ID: 26355346
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential Responses of Retinal Neurons and Glia Revealed via Proteomic Analysis on Primary and Secondary Retinal Ganglion Cell Degeneration.
    Kwong JMK; Caprioli J; Lee JCY; Song Y; Yu FJ; Bian J; Sze YH; Li KK; Do CW; To CH; Lam TC
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synuclein Proteins in Cancer Development and Progression.
    Zanotti LC; Malizia F; Cesatti Laluce N; Avila A; Mamberto M; Anselmino LE; Menacho-Márquez M
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer.
    Li Y; Pan Q; Cheng M; Wu Z
    Aging (Albany NY); 2023 Mar; 15(7):2541-2553. PubMed ID: 36996495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-retinal ganglion cell markers in mice, rats, and rhesus macaques.
    Nadal-Nicolás FM; Galindo-Romero C; Lucas-Ruiz F; Marsh-Amstrong N; Li W; Vidal-Sanz M; Agudo-Barriuso M
    Zool Res; 2023 Jan; 44(1):226-248. PubMed ID: 36594396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma synuclein promotes cancer metastasis through the MKK3/6-p38MAPK cascade.
    Liu J; Shao T; Zhang J; Liu Q; Hua H; Zhang H; Wang J; Luo T; Shi YE; Jiang Y
    Int J Biol Sci; 2022; 18(8):3167-3177. PubMed ID: 35637967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
    Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
    Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.